A Computer-Driven Approach to Discover Natural Product Leads for Methicillin-Resistant Staphylococcus aureus Infection Therapy

The risk of methicillin-resistant Staphylococcus aureus (MRSA) infection is increasing in both the developed and developing countries. New approaches to overcome this problem are in need. A ligand-based strategy to discover new inhibiting agents against MRSA infection was built through exploration of machine learning techniques. This strategy is based in two quantitative structure–activity relationship (QSAR) studies, one using molecular descriptors (approach A) and the other using descriptors (approach B). In the approach A, regression models were developed using a total of 6645 molecules that were extracted from the ChEMBL, PubChem and ZINC databases, and recent literature. The performance of the regression models was successfully evaluated by internal and external validation, the best model achieved R2 of 0.68 and RMSE of 0.59 for the test set. In general natural product (NP) drug discovery is a time-consuming process and several strategies for dereplication have been developed to overcome this inherent limitation. In the approach B, we developed a new NP drug discovery methodology that consists in frontloading samples with 1D NMR descriptors to predict compounds with antibacterial activity prior to bioactivity screening for NPs discovery. The NMR QSAR classification models were built using 1D NMR data (1H and 13C) as descriptors, from crude extracts, fractions and pure compounds obtained from actinobacteria isolated from marine sediments collected off the Madeira Archipelago. The overall predictability accuracies of the best model exceeded 77% for both training and test sets.

[1]  B. Sridhar,et al.  Design, synthesis, and biological evaluation of indolylidinepyrazolones as potential anti-bacterial agents , 2014 .

[2]  Susana P. Gaudêncio,et al.  In Silico HCT116 Human Colon Cancer Cell-Based Models En Route to the Discovery of Lead-Like Anticancer Drugs , 2018, Biomolecules.

[3]  Zhiyong Li,et al.  Marine actinobacteria associated with marine organisms and their potentials in producing pharmaceutical natural products , 2014, Applied Microbiology and Biotechnology.

[4]  Yoonkyung Park,et al.  Marine Peptides and Their Anti-Infective Activities , 2015, Marine drugs.

[5]  W. Wohlleben,et al.  Antibiotic drug discovery , 2016, Microbial biotechnology.

[6]  H. Koga,et al.  Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids. , 1980, Journal of medicinal chemistry.

[7]  Gang Fu,et al.  PubChem Substance and Compound databases , 2015, Nucleic Acids Res..

[8]  João Aires-de-Sousa,et al.  JATOON: Java tools for neural networks , 2002 .

[9]  Dilip K. Rai,et al.  Current Status and Future Prospects of Marine Natural Products (MNPs) as Antimicrobials , 2017, Marine drugs.

[10]  Samuel V. Angiuoli,et al.  Insights on Evolution of Virulence and Resistance from the Complete Genome Analysis of an Early Methicillin-Resistant Staphylococcus aureus Strain and a Biofilm-Producing Methicillin-Resistant Staphylococcus epidermidis Strain , 2005, Journal of bacteriology.

[11]  D. Pompliano,et al.  Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.

[12]  C. Fjell,et al.  Identification of novel antibacterial peptides by chemoinformatics and machine learning. , 2009, Journal of medicinal chemistry.

[13]  John J. Irwin,et al.  ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..

[14]  Susana P. Gaudêncio,et al.  A Chemoinformatics Approach to the Discovery of Lead-Like Molecules from Marine and Microbial Sources En Route to Antitumor and Antibiotic Drugs , 2014, Marine drugs.

[15]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[16]  Florbela Pereira,et al.  Computational Methodologies in the Exploration of Marine Natural Product Leads , 2018, Marine drugs.

[17]  P. Selzer,et al.  Identification and Classification of GPCR Ligands Using Self‐Organizing Neural Networks , 2005 .

[18]  Katsuhiko Mitachi,et al.  Advances in MRSA drug discovery: where are we and where do we need to be? , 2013, Expert opinion on drug discovery.

[19]  S. Solomon,et al.  Antibiotic resistance threats in the United States: stepping back from the brink. , 2014, American family physician.

[20]  Susana P. Gaudêncio,et al.  The Madeira Archipelago As a Significant Source of Marine-Derived Actinomycete Diversity with Anticancer and Antimicrobial Potential , 2016, Front. Microbiol..

[21]  George Papadatos,et al.  The ChEMBL database in 2017 , 2016, Nucleic Acids Res..

[22]  Ian H. Witten,et al.  The WEKA data mining software: an update , 2009, SKDD.

[23]  M. J. Duart,et al.  Topological pattern for the search of new active drugs against methicillin resistant Staphylococcus aureus. , 2017, European journal of medicinal chemistry.

[24]  D. Newman,et al.  Drugs and Drug Candidates from Marine Sources: An Assessment of the Current “State of Play” , 2016, Planta Medica.

[25]  J. Bérdy Bioactive Microbial Metabolites A Personal View , 2005 .

[26]  R. Fani,et al.  Antibiotics from Deep-Sea Microorganisms: Current Discoveries and Perspectives , 2018, Marine drugs.

[27]  B. Kos,et al.  Antibiotic resistance mechanisms in bacteria: biochemical and genetic aspects. , 2008 .

[28]  B. Narasimhan,et al.  Synthesis, antimycobacterial, antiviral, antimicrobial activity and QSAR studies of N(2)-acyl isonicotinic acid hydrazide derivatives. , 2012, Medicinal chemistry (Shariqah (United Arab Emirates)).

[29]  Zhuhua Luo,et al.  Antimicrobial activity and molecular docking studies of a novel anthraquinone from a marine-derived fungus Aspergillus versicolor , 2018, Natural product research.

[30]  Tanfeng Zhao,et al.  A QSPR approach for the fast estimation of DFT/NBO partial atomic charges☆ , 2014 .

[31]  J. Gálvez,et al.  Molecular topology: A new strategy for antimicrobial resistance control. , 2017, European journal of medicinal chemistry.

[32]  Petra Schneider,et al.  Hybrid Network Model for “Deep Learning” of Chemical Data: Application to Antimicrobial Peptides , 2017, Molecular informatics.

[33]  P. Proksch,et al.  Spiromastixones A-O, antibacterial chlorodepsidones from a deep-sea-derived Spiromastix sp. fungus. , 2014, Journal of natural products.

[34]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[35]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[36]  CHUN WEI YAP,et al.  PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints , 2011, J. Comput. Chem..

[37]  Paul W. Finn,et al.  Are the physicochemical properties of antibacterial compounds really different from other drugs? , 2016, Journal of Cheminformatics.

[38]  Sidharth Chopra,et al.  New drugs for methicillin-resistant Staphylococcus aureus: an update. , 2013, The Journal of antimicrobial chemotherapy.

[39]  T. Ng,et al.  Antibacterial products of marine organisms , 2015, Applied Microbiology and Biotechnology.

[40]  R. W. Hansen,et al.  Journal of Health Economics , 2016 .

[41]  Stefan Günther,et al.  StreptomeDB 2.0—an extended resource of natural products produced by streptomycetes , 2015, Nucleic Acids Res..

[42]  M. Gleeson Generation of a set of simple, interpretable ADMET rules of thumb. , 2008, Journal of medicinal chemistry.

[43]  Harshinder Singh,et al.  Application of the Random Forest Method in Studies of Local Lymph Node Assay Based Skin Sensitization Data , 2005, J. Chem. Inf. Model..

[44]  Long Li,et al.  Discovering New Agents Active against Methicillin-Resistant Staphylococcus aureus with Ligand-Based Approaches , 2014, J. Chem. Inf. Model..

[45]  William Fenical,et al.  Pharmacological Properties of the Marine Natural Product Marinopyrrole A against Methicillin-Resistant Staphylococcus aureus , 2011, Antimicrobial Agents and Chemotherapy.

[46]  Robert P. Sheridan,et al.  Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling , 2003, J. Chem. Inf. Comput. Sci..

[47]  A. Bull,et al.  Abyssomicin C-A polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway. , 2004, Angewandte Chemie.

[48]  C. Gattass,et al.  Topological polar surface area defines substrate transport by multidrug resistance associated protein 1 (MRP1/ABCC1). , 2009, Journal of medicinal chemistry.

[49]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[50]  János Bérdy,et al.  Bioactive microbial metabolites. , 2005, The Journal of antibiotics.

[51]  Corinna Cortes,et al.  Support-Vector Networks , 1995, Machine Learning.

[52]  M. Faramarzi,et al.  Synthesis, antibacterial activity, and quantitative structure-activity relationships of new (Z)-2-(nitroimidazolylmethylene)-3(2H)-benzofuranone derivatives. , 2007, Bioorganic & medicinal chemistry letters.